Results 111 to 120 of about 23,909 (233)

Development of Pure Certified Reference Material of Cannabidiol [PDF]

Congcong Yu, Ruihan Long, Feng Cao, Xinying Zhao, Tao Lan, Dunming Xu   +5 more
openalex   +1 more source

Pharmacology and legal status of cannabidiol.

, 2021
Pietro Brunetti, Alfredo Fabrizio Lo Faro, Filippo Pirani, Paolo Berretta, Roberta Pacifici, Simona Pichini, Francesco Paolo Busardò   +6 more
openalex   +2 more sources

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders [PDF]

, 2020
María S. García‐Gutiérrez, Francisco Navarrete, Ani Gasparyan, Amaya Austrich-Olivares, F. Sala, Jorge Manzanares   +5 more
openalex   +1 more source

A single dose of cannabidiol (CBD) positively influences measures of stress in dogs during separation and car travel [PDF]

, 2023
Alysia B. G. Hunt, Hannah E. Flint, Darren W. Logan, Tammie King   +3 more
openalex   +1 more source

Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease

Epilepsia, EarlyView.
Abstract Background and Objective Lafora disease (LD) is a rare progressive disorder caused by mutations in the EPM2A or EPM2B genes, characterized by the accumulation of Lafora bodies, drug‐resistant epilepsy, and cognitive decline. To investigate the early molecular mechanisms of LD, we studied electrophysiological changes in the dentate gyrus (DG ...
Cinzia Costa, Laura Bellingacci, Jacopo Canonichesi, Valentina Imperatore, Anna Aurora Taddei, Luis Zafra‐Puerta, Nerea Iglesias‐Cabeza, Paolo Prontera, Andrea Mancini, Massimiliano Di Filippo, Alessandro Tozzi, Katiuscia Martinello, Marta Barzasi, Fabrizio Gardoni, Marina P. Sánchez, José M. Serratosa, Lucilla Parnetti, Miriam Sciaccaluga   +17 more
wiley   +1 more source

Methodologies for developing and applying consensus‐based recommendations in epilepsy care: A narrative review

Epilepsia, EarlyView.
Abstract Consensus‐based recommendations (CBRs) are essential for health care decision‐making when evidence is limited or conflicting. They can be developed using established methodologies such as the Delphi technique, the nominal group technique (NGT), and the RAND Corporation/University of California Los Angeles (UCLA) Appropriateness Method (RAM ...
Rowan Haffner, Brian Mathew, Francesco Brigo, Anila Qasim, Victoria San Antonio‐Arce, Houda Ben Ayed, Edoardo Ferlazzo, Churl‐Su Kwon, Kheng Seang Lim, James W. Mitchell, Muhammad A. Salisu, Kette Valente, Kollencheri Puthenveettil Vinayan, Colin B. Josephson, Nathalie Jette   +14 more
wiley   +1 more source

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats [PDF]

, 2020
Olga Sadowska, Marta Baranowska‐Kuczko, Anna Gromotowicz‐Poplawska, Michał Biernacki, Aleksandra Kicman, Barbara Malinowska, Irena Kasacka, Anna Krzyżewska, Hanna Kozłowska   +8 more
openalex   +1 more source

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the efficacy of cannabis for the treatment of acute migraine. Background Preclinical and retrospective studies suggest cannabinoids may be effective in migraine treatment. However, there have been no randomized clinical trials examining the efficacy of cannabinoids for acute migraine.
Nathaniel M. Schuster, Mark S. Wallace, Thomas D. Marcotte, Dawn C. Buse, Euyhyun Lee, Lin Liu, Michelle Sexton   +6 more
wiley   +1 more source

Novel cannabidiol and anandamide analogs [PDF]

, 2012
Marsha Rebecca D'Souza
openalex   +1 more source

Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network [PDF]

, 2022
Francesca Mottarlini, Marco Fumagalli, Fernando Castillo Díaz, Stefano Piazza, Giorgia Targa, Enrico Sangiovanni, Barbara Pacchetti, Mikael H. Sodergren, Mario Dell’Agli, Fabio Fumagalli, Lucia Caffino   +10 more
openalex   +1 more source